SD

Swarnima Das

Active Director Director DIN 10608330
DIN 10608330 First appointment Apr 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value •••• Premium profile

About Swarnima Das

Data last updated:

Swarnima Das is a Director at Capital Cure Healthcare Private Limited (since 2024). The company operates in Healthcare. Capital Cure Healthcare Private Limited reported revenue of ₹29.8 Lakh (FY 2025).

DIN 10608330
Primary Designation Director
Industry Healthcare
First Appointment 27 Apr 2024
Oldest Company Age 4 yrs
Largest company Capital Cure Healthcare Private Limited · ₹29.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Apr 20242022₹29.8 Lakh (FY 2025)Active

Board colleagues of Swarnima Das

Directorship timeline

Open interactive timeline →
Capital Cure Healthcare Private Limited
Premium access

Shareholding and investment profile for Swarnima Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swarnima Das

Swarnima Das currently holds 1 directorship: Capital Cure Healthcare Private Limited (Director, since 27 Apr 2024, revenue ₹29.8 Lakh (FY 2025)).

Swarnima Das was first appointed on 27 Apr 2024 as Director at Capital Cure Healthcare Private Limited.

The current boards of Swarnima Das's companies include Ganda Aurobinda Mohapatra (Capital Cure Healthcare Private Limited), Saurav Narayan Nanda (Capital Cure Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available